3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Total serum FGF-21 levels positively relate to visceral adiposity differently from its functional intact form

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective

          Increased Fibroblast Growth Factor-21 (FGF-21) circulating levels have been described in obesity. In this observational study, we analysed a group of subjects with metabolic disorders to unravel the putative link between visceral adiposity and FGF-21 serum levels.

          Methods

          Total and intact serum FGF-21 concentration was measured with an ELISA assay respectively in 51 and 46 subjects, comparing FGF-21 levels in dysmetabolic conditions. We also tested Spearman’s correlations between FGF-21 serum levels and biochemical and clinical metabolic parameters.

          Results

          FGF-21 was not significantly increased in high-risk conditions such as visceral obesity, Metabolic Syndrome, diabetes, smoking, and atherosclerosis. Waist Circumference (WC), but not BMI, positively correlated with total FGF-21 levels (r=0.31, p <0.05), while HDL-cholesterol (r=-0.29, p <0.05) and 25-OH Vitamin D (r=-0.32, p <0.05) showed a significant negative correlation with total FGF-21. ROC analysis of FGF-21 in prediction of increased WC, showed that patients with total FGF-21 level over cut-off value of 161.47 pg/mL presented with impaired FPG. Conversely, serum levels of the intact form of FGF-21 did not correlate with WC and other metabolic biomarkers.

          Conclusion

          Our newly calculated cut-off for total FGF-21 according to visceral adiposity identified subjects with fasting hyperglycemia. However, waist circumference correlates with total FGF-21 serum levels but does not correlate with intact FGF-21, suggesting that functional FGF-21 does not necessarily relate with obesity and metabolic features.

          Related collections

          Most cited references53

          • Record: found
          • Abstract: not found
          • Article: not found

          Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021

            (2020)
            The American Diabetes Association (ADA) "Standards of Medical Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee (https://doi.org/10.2337/dc21-SPPC), are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations, please refer to the Standards of Care Introduction (https://doi.org/10.2337/dc21-SINT). Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Fibroblast growth factor-21 regulates PPARγ activity and the antidiabetic actions of thiazolidinediones.

              Fibroblast growth factor-21 (FGF21) is a circulating hepatokine that beneficially affects carbohydrate and lipid metabolism. Here, we report that FGF21 is also an inducible, fed-state autocrine factor in adipose tissue that functions in a feed-forward loop to regulate the activity of peroxisome proliferator-activated receptor γ (PPARγ), a master transcriptional regulator of adipogenesis. FGF21 knockout (KO) mice display defects in PPARγ signaling including decreased body fat and attenuation of PPARγ-dependent gene expression. Moreover, FGF21-KO mice are refractory to both the beneficial insulin-sensitizing effects and the detrimental weight gain and edema side effects of the PPARγ agonist rosiglitazone. This loss of function in FGF21-KO mice is coincident with a marked increase in the sumoylation of PPARγ, which reduces its transcriptional activity. Adding back FGF21 prevents sumoylation and restores PPARγ activity. Collectively, these results reveal FGF21 as a key mediator of the physiologic and pharmacologic actions of PPARγ. Copyright © 2012 Elsevier Inc. All rights reserved.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Endocrinol (Lausanne)
                Front Endocrinol (Lausanne)
                Front. Endocrinol.
                Frontiers in Endocrinology
                Frontiers Media S.A.
                1664-2392
                20 June 2023
                2023
                : 14
                : 1159127
                Affiliations
                [1] 1 Department of Interdisciplinary Medicine, University of Bari “Aldo Moro” , Bari, Italy
                [2] 2 Department of Biosciences and Nutrition, Karolinska Institutet , Huddinge, Sweden
                [3] 3 National Institute for Biostructures and Biosystems (INBB) , Rome, Italy
                Author notes

                Edited by: Ana Luísa De Sousa-Coelho, Algarve Biomedical Center Research Institute (ABC-RI), Portugal

                Reviewed by: Thomas Bobbert, Charité University Medicine Berlin, Germany; Mette Bjerre, Aarhus University, Denmark

                *Correspondence: Raffaella Maria Gadaleta, raffaella.gadaleta@ 123456uniba.it ; Antonio Moschetta, antonio.moschetta@ 123456uniba.it

                †These authors share first authorship

                ‡These authors have contributed equally to this work and share senior authorship

                Article
                10.3389/fendo.2023.1159127
                10319105
                37409233
                78d46690-8062-4e76-b9df-70bce54b31a1
                Copyright © 2023 Crudele, Garcia-Irigoyen, Cariello, Piglionica, Scialpi, Florio, Piazzolla, Suppressa, Sabbà, Gadaleta and Moschetta

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 06 February 2023
                : 29 May 2023
                Page count
                Figures: 5, Tables: 2, Equations: 0, References: 53, Pages: 11, Words: 4668
                Funding
                AM is funded by EU-JPI HDL-INTIMIC –MIUR FATMAL; MIUR-PON “R&I” 2014–2020 “BIOMIS” cod.ARS01_01220; POR Puglia FESR—FSE 2014– 2020, “INNOMA” cod. 4TCJLV4; National Recovery and Resilience Plan (NRRP), Mission 4 Component 2 Investment 1.3 - Call for tender No. 341 of 15 March 2022 of Italian Ministry of University and Research funded by the European Union – NextGenerationEU; Award Number: Project code PE00000003, Concession Decree No. 1550 of 11 October 2022 adopted by the Italian Ministry of University and Research, CUP D93C22000890001, Project title “ON Foods - Research and innovation network on food and nutrition Sustainability, Safety and Security – Working ON Foods”.
                Categories
                Endocrinology
                Original Research
                Custom metadata
                Obesity

                Endocrinology & Diabetes
                visceral obesity,hdl cholesterol,intact fgf21,waist circumference,vitamin d

                Comments

                Comment on this article